Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling-Reference-Cited by-同舟云学术

Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling

Published:2015-07-15 Issue:7 Volume:10 Page:e0129866
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cipriani Sabrina,Renga Barbara,D’Amore Claudio,Simonetti Michele,De Tursi Antonio Angelo,Carino Adriana,Monti Maria Chiara,Sepe Valentina,Zampella Angela,Fiorucci Stefano

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. The genetics of complex cholestatic disorders;GM Hirschfield;Gastroenterology,2013

2. Primary sclerosing cholangitis: a review and update on therapeutic developments;JH Tabibian;Expert Rev Gastroenterol Hepatol,2013

3. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management;JE Eaton;Gastroenterology,2013

4. Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship;E Sinakos;Inflamm Bowel Dis,2013

5. Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action;R Poupon;Clin Res Hepatol Gastroenterol,2012

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BAR502/fibrate conjugates: synthesis, biological evaluation and metabolic profile;Frontiers in Chemistry;2024-07-17

2. Sodium/bile acid co-transporter inhibitors currently in preclinical or early clinical development for the treatment of primary biliary cholangitis;Expert Opinion on Investigational Drugs;2024-04-24

3. The role of bile acid receptor TGR5 in regulating inflammatory signalling;Scandinavian Journal of Immunology;2024-02-02

4. Bile Acids in Autoimmune Liver Disease: Unveiling the Nexus of Inflammation, Inflammatory Cells, and Treatment Strategies;Cells;2023-11-29

5. Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders;Biochemical Pharmacology;2023-10